Assembly Biosciences Inc.

2.18-0.0900-3.96%Vol 519.64K1Y Perf -44.23%
Jun 24th, 2022 16:00 DELAYED
BID2.10 ASK2.24
Open2.25 Previous Close2.27
Pre-Market- After-Market-
 - -  - -%
Target Price
5.50 
Analyst Rating
Moderate Buy 2.33
Potential %
152.29 
Finscreener Ranking
★+     43.41
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     49.76
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     41.17
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
30.18 
Earnings Rating
Sell
Market Cap105.11M 
Earnings Date
4th Aug 2022
Alpha-0.03 Standard Deviation0.21
Beta0.87 

Today's Price Range

2.162.27

52W Range

1.324.17

5 Year PE Ratio Range

-7.70-4.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
9.00%
1 Month
28.99%
3 Months
-0.46%
6 Months
-3.96%
1 Year
-44.23%
3 Years
-84.27%
5 Years
-89.57%
10 Years
-91.31%

TickerPriceChg.Chg.%
ASMB2.18-0.0900-3.96
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
ValuationValueIndustryS&P 500US Markets
-0.70
0.66
15.42
414.90
-1.10
-1.93
0.66
3.04
-20 863 100.00
Forward PE-1.21
PEG-
Financial StrengthValueIndustryS&P 500US Markets
11.50
12.20
0.02
0.04
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-
-1 390.40
-1 382.70
-798.50
-81.40
RevenueValueIndustryS&P 500US Markets
6.25M
0.13
-19.22
43.16
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.49-0.482.04
Q04 2021-0.50-0.4118.00
Q03 2021-0.55-0.4125.45
Q02 2021-0.64-0.5514.06
Q01 2021-0.79-0.6912.66
Q04 2020-0.90-1.11-23.33
Q03 2020-0.78-0.0988.46
Q02 2020-0.030.19733.33
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.52-8.33Negative
9/2022 QR-0.55-41.03Negative
12/2022 FY-2.130.93Positive
12/2023 FY-1.6912.89Positive
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.52
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume519.64K
Shares Outstanding48.22K
Shares Float47.64M
Trades Count2.85K
Dollar Volume1.15M
Avg. Volume618.24K
Avg. Weekly Volume656.23K
Avg. Monthly Volume705.59K
Avg. Quarterly Volume492.90K

Assembly Biosciences Inc. (NASDAQ: ASMB) stock closed at 2.18 per share at the end of the most recent trading day (a -3.96% change compared to the prior day closing price) with a volume of 519.64K shares and market capitalization of 105.11M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 120 people. Assembly Biosciences Inc. CEO is John G. McHutchison.

The one-year performance of Assembly Biosciences Inc. stock is -44.23%, while year-to-date (YTD) performance is -6.44%. ASMB stock has a five-year performance of -89.57%. Its 52-week range is between 1.3199 and 4.17, which gives ASMB stock a 52-week price range ratio of 30.18%

Assembly Biosciences Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 0.66, a price-to-sale (PS) ratio of 15.42, a price to cashflow ratio of 414.90, a PEG ratio of 2.32, a ROA of -59.02%, a ROC of -61.75% and a ROE of -66.14%. The company’s profit margin is -81.40%, its EBITDA margin is -1 382.70%, and its revenue ttm is $6.25 Million , which makes it $0.13 revenue per share.

Of the last four earnings reports from Assembly Biosciences Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.52 for the next earnings report. Assembly Biosciences Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Assembly Biosciences Inc. is Moderate Buy (2.33), with a target price of $5.5, which is +152.29% compared to the current price. The earnings rating for Assembly Biosciences Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Assembly Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Assembly Biosciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.76, ATR14 : 0.14, CCI20 : 123.78, Chaikin Money Flow : -0.06, MACD : 0.09, Money Flow Index : 50.29, ROC : 3.32, RSI : 60.74, STOCH (14,3) : 78.95, STOCH RSI : 0.64, UO : 53.34, Williams %R : -21.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Assembly Biosciences Inc. in the last 12-months were: Jason A. Okazaki (Sold 5 886 shares of value $13 113 ), John G. McHutchison (Sold 16 770 shares of value $53 781 ), Luisa M. Stamm (Sold 1 038 shares of value $2 250 ), Michael P. Samar (Sold 2 285 shares of value $4 953 ), William E. Delaney (Sold 1 038 shares of value $2 250 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.33

Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

CEO: John G. McHutchison

Telephone: +1 833 509-4583

Address: 331 Oyster Point Blvd, South San Francisco 94080, CA, US

Number of employees: 120

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

70%30%

Bearish Bullish

68%32%

Bearish Bullish

62%38%

TipRanks News for ASMB

News

Stocktwits